Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Promising preclinical results of novel gene therapy against Niemann-Pick disease

May 30, 2007

Novel xanthine oxidase inhibitors for gout emerge from Kissei R&D

May 28, 2007

Increlex recommended for approval in E.U.

May 28, 2007

Preterax evaluation closes in ADVANCE diabetes trial

May 28, 2007

Marketing agreement signed for PSD-502 for premature ejaculation

May 28, 2007

PSN-GK1: a glucokinase activator with glucose-lowering and insulinotropic activity in vivo

May 28, 2007

Recent Tsumura patents impart novel therapeutic agents for diabetic retinopathy

May 28, 2007

Levitra 20 mg tablet approved in Japan

May 25, 2007

Salvacyl/Moapar completes European mutual recognition procedure

May 25, 2007

Mircera recommended for approval in E.U.

May 25, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...